Case-control Study- Cancer Pain: Uncontrolled Pain as Depression Development Predictor in Oncologic Patients (Fentanyl)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

271 participants

Study Classification

OBSERVATIONAL

Study Start Date

2007-11-30

Study Completion Date

2008-03-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to evaluate the relationship between cancer pain and risk of depression among cancer patients.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Correlation Between the Analgesic Effect of Fentanyl Transdermal Patches and Nutritional Status in Cancer Pain Patients

NCT06369961

Cancer Pain Nutrition Disorders

COMPLETED

Fentanyl Matrix Application for Cancer Pain: Multicenter, Prospective, Observational Study

NCT01816503

Pain

COMPLETED

Nasal Fentanyl for Chronic Cancer Pain

NCT01906073

Cancer Pain

WITHDRAWN PHASE3

Prospective Study About Clinical and Pharmacogenetic Safety of Opioid Use for Chronic Pain

NCT00916890

Chronic Pain

SUSPENDED PHASE4

Prospective Longitudinal Observational Study to Evaluate the Clinical Characteristics and Opioids Treatments in Patients With Breakthrough Cancer Pain

NCT01946555

Tumor Cancer Pain Breakthrough Cancer Pain +1 more

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a retrospective observational and case-control multicenter study. The main objective of this study is determine the degree of association between cancer pain and depression by impact assessment of adequate control of pain associated with cancer risk depression in patients attending the Oncology Unit. The assessment of pain intensity will be performed by using visual analogue scales (EVAs) and verbal descriptive scales, as an observational study, not limit or modify the use of any drug. The patients included in this study have a medical history of cancer pain and mild depression (Beck = 8). The controls are patients with history of cancer pain and mild or absent depression (Beck = 7). n/a

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Cancer Pain

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

001

Visual analogue scales (EVAs) This scale measures the pain intensity.

Visual analogue scales (EVAs)

Intervention Type OTHER

This scale measures the pain intensity.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Visual analogue scales (EVAs)

This scale measures the pain intensity.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Patients =18 years old
* have medical data of = 3 months
* experience pain after cancer diagnosis and complete the Beck Depression Inventory (BDI)
* patients who give informed written consent
* patients with no mental or physical disorders that unable them to complete the BDI.

Exclusion Criteria

* Patients with diagnosis of depression before cancer diagnosis
* patients with chronic pain prior to the diagnosis of cancer, and cancer disease has not changed its course
* patients with other previous mental disorders
* patients who do not give their informed written consent.

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No